Develops off-the-shelf NK and CAR-T cell therapies engineered from healthy donors to treat various cancers.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Wugen is specializing in developing off-the-shelf cellular therapies for cancer treatment. Utilizing its proprietary Moneta™ platform, Wugen engineers memory natural killer (NK) and CAR-T cells derived from healthy donors to enhance anti-tumor activity without the risk of graft-versus-host disease. The company’s investigational therapies target hematologic and solid tumor malignancies, aiming to provide accessible and effective treatment options for patients.
Wugen Funding
Sign up to gain insights into Wugen funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series C | Aug 27, 2025 | 110M | ||
| Series C | Aug 27, 2025 | 5M | ||
| Series B | Jul 09, 2021 | 99M | ||
| Series A | Apr 13, 2020 | 37M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market Tape D®
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Wugen Management Team
Investors
Abingworth Management
LYZZ Capital
Intermediate Capital Group
Tybourne Capital Management
Lightchain
RiverVest Venture Partners
Aisling Capital
Fidelity
Wugen Valuations & Financials
View real-time NPM data on Wugen stock including most recent valuation and historical share price information. Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.
Similar Companies
like Wugen
Cityblock Health
Health Care
Tech-driven care provider for communities with complex needs.
Benchling
Health Care
Cloud based platform for research and development in biotechnology.
Lyra
Health Care
Digital health startup using technology to connect companies and employees to mental health providers.
Eikon Therapeutics
Health Care
Uses revolutionary technology to discover novel treatments for life-threatening diseases.
Tonal
Health Care
Delivers AI-powered strength training with digital weights and personalized coaching.
Devoted
Health Care
Provides Medicare Advantage plans to improve older Americans' well-being with comprehensive and family-oriented care.
Color Genomics
Health Care
Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.
FAQ
We have answers
Wugen stock does not trade on public stock exchanges. Wugen stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Wugen stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Wugen Stock does not trade on public stock exchanges. In order to sell Wugen shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Wugen does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Wugen share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Wugen stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Wugen stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Wugen stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Wugen is a private company and has not had an IPO. There is currently no Wugen IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Wugen IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
